TRA2B anticorps
Aperçu rapide pour TRA2B anticorps (ABIN7466391)
Antigène
Voir toutes TRA2B AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Réactivité croisée
- Humain, Souris, Rat
-
Purification
- Purified by antigen-affinity chromatography.
-
Immunogène
- Recombinant protein encompassing a sequence within the center region of human TRA2B. The exact sequence is proprietary.
-
Isotype
- IgG
-
-
-
-
Indications d'application
- WB: 1:500-1:3000. IHC-P: 1:100-1:1000. Optimal dilutions/concentrations should be determined by the researcher. Not tested in other applications.
-
Commentaires
-
Positive Control: Jurkat
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.41 mg/mL
-
Buffer
- 0.1M Tris-Glycine ( pH 7), 20 % Glycerol, 0.01 % Thimerosal
-
Agent conservateur
- Thimerosal (Merthiolate)
-
Précaution d'utilisation
- This product contains Thimerosal (Merthiolate): a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- 4 °C,-20 °C
-
Stockage commentaire
- Store as concentrated solution. Centrifuge briefly prior to opening vial. For short-term storage (1-2 weeks), store at 4°C. For long-term storage, aliquot and store at -20°C or below. Avoid multiple freeze-thaw cycles.
-
-
- TRA2B (Transformer 2 beta Homolog (TRA2B))
-
Autre désignation
- transformer 2 beta homolog
-
Sujet
- Transformer 2 beta homolog , Htra2-beta , PPP1R156 , SFRS10 , SRFS10 , TRA2-BETA , TRAN2B,Sequence-specific RNA-binding protein which participates in the control of pre-mRNA splicing.
-
Poids moléculaire
- 34 kDa
-
ID gène
- 6434
-
UniProt
- P62995
Antigène
-